U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
ORVACABTAGENE AUTOLEUCEL
USAN   INN  
Official Name English
JCARH-125
Preferred Name English
ORVACABTAGENE AUTOLEUCEL [USAN]
Common Name English
JCARH125
Code English
Orvacabtagene autoleucel [WHO-DD]
Common Name English
JCARH125 CONSISTS OF HUMAN CULTURE EXPANDED GENETICALLY MODIFIED AUTOLOGOUS T CELLS FOR CELL-BASED GENE THERAPY. CD4+ CD8+ T CELLS ARE DERIVED FROM ISOLATED BLOOD OF THE PATIENT AND ARE TRANSDUCED WITH NON-REPLICATIVE SELF-INACTIVATING (SIN) LENTIVIRAL V
Common Name English
orvacabtagene autoleucel [INN]
Common Name English
Code System Code Type Description
INN
11274
Created by admin on Wed Apr 02 02:13:03 GMT 2025 , Edited by admin on Wed Apr 02 02:13:03 GMT 2025
PRIMARY
SMS_ID
300000006020
Created by admin on Wed Apr 02 02:13:03 GMT 2025 , Edited by admin on Wed Apr 02 02:13:03 GMT 2025
PRIMARY
USAN
GH-22
Created by admin on Wed Apr 02 02:13:03 GMT 2025 , Edited by admin on Wed Apr 02 02:13:03 GMT 2025
PRIMARY
FDA UNII
K8RW1TW3EM
Created by admin on Wed Apr 02 02:13:03 GMT 2025 , Edited by admin on Wed Apr 02 02:13:03 GMT 2025
PRIMARY
NCI_THESAURUS
C147523
Created by admin on Wed Apr 02 02:13:03 GMT 2025 , Edited by admin on Wed Apr 02 02:13:03 GMT 2025
PRIMARY
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966